Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre P A Theocharides

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Leukemia|May 7, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosisAnne Kaiser, Veronika Lysenko, Renier Myburgh, et al.
Cell Chemical Biology|March 23, 2021
Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyriaFrançois Halloy, Pavithra S Iyer, Alice Ghidini, et al.
Blood Advances|June 6, 2020
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG miceVeronika Lysenko, Nicole Wildner-Verhey van Wijk, Kathrin Zimmermann, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Cancer Research|March 31, 2025
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative EffectNancy Klemm, Roman R Schimmer, Nils K Konrad, et al.
Nature Cancer|August 7, 2023
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasmsElodie Grockowiak, Claudia Korn, Justyna Rak, et al.
Cell Reports|June 9, 2021
An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synucleinEleanna Kara, Alessandro Crimi, Anne Wiedmer, et al.
Nature Communications|October 31, 2024
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature Medicine|August 1, 2025
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Leukemia|May 7, 2026
CAR T-cells targeting CD117 effectively eliminate mast cells in preclinical models of advanced systemic mastocytosisAnne Kaiser, Veronika Lysenko, Renier Myburgh, et al.
Cell Chemical Biology|March 23, 2021
Repurposing of glycine transport inhibitors for the treatment of erythropoietic protoporphyriaFrançois Halloy, Pavithra S Iyer, Alice Ghidini, et al.
Blood Advances|June 6, 2020
Enhanced engraftment of human myelofibrosis stem and progenitor cells in MISTRG miceVeronika Lysenko, Nicole Wildner-Verhey van Wijk, Kathrin Zimmermann, et al.
Nature Communications|October 12, 2023
Proteogenetic drug response profiling elucidates targetable vulnerabilities of myelofibrosisMattheus H E Wildschut, Julien Mena, Cyril Dördelmann, et al.
Cancer Research|March 31, 2025
The Prolonged Half-Life of the p53 Missense Variant R248Q Promotes Accumulation and Heterotetramer Formation with Wild-Type p53 to Exert the Dominant-Negative EffectNancy Klemm, Roman R Schimmer, Nils K Konrad, et al.
Nature Cancer|August 7, 2023
Different niches for stem cells carrying the same oncogenic driver affect pathogenesis and therapy response in myeloproliferative neoplasmsElodie Grockowiak, Claudia Korn, Justyna Rak, et al.
Cell Reports|June 9, 2021
An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synucleinEleanna Kara, Alessandro Crimi, Anne Wiedmer, et al.
Nature Communications|October 31, 2024
Single-cell landscape of innate and acquired drug resistance in acute myeloid leukemiaRebekka Wegmann, Ximena Bonilla, Ruben Casanova, et al.
Cancer Cell|January 22, 2021
The Tumor Profiler Study: integrated, multi-omic, functional tumor profiling for clinical decision supportAnja Irmisch, Ximena Bonilla, Stéphane Chevrier, et al.
Nature Medicine|August 1, 2025
Publisher Correction: Feasibility of multiomics tumor profiling for guiding treatment of melanomaNicola Miglino, Nora C Toussaint, Alexander Ring, et al.
Pageof 4